Clinical Trials
2 trialsNCT02812524 2026-04-24
Ipilimumab for Head and Neck Cancer Patients
Providence Health & Services
Phase 1 Active not recruiting
NCT02919683 2026-01-28
Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity
Dana-Farber Cancer Institute
Phase 2 Active not recruiting